BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32030888)

  • 1. Increasing Tim-3+CD244+, Tim-3+CD57+, and Tim-3+PD-1+ T cells in patients with acute myeloid leukemia.
    Tan J; Huang S; Huang J; Yu Z; Chen Y; Lu Y; Li Y; Chen S
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):137-141. PubMed ID: 32030888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S
    Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased exhausted CD8
    Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML.
    Tan J; Yu Z; Huang J; Chen Y; Huang S; Yao D; Xu L; Lu Y; Chen S; Li Y
    Biomark Res; 2020; 8():6. PubMed ID: 32082573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher frequency of the CTLA-4
    Chen Y; Tan J; Huang S; Huang X; Huang J; Chen J; Yu Z; Lu Y; Weng J; Du X; Li Y; Zha X; Chen S
    Asia Pac J Clin Oncol; 2020 Apr; 16(2):e12-e18. PubMed ID: 31612643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with
    Tan J; Chen S; Lu Y; Yao D; Xu L; Zhang Y; Yang L; Chen J; Lai J; Yu Z; Zhu K; Li Y
    Chin J Cancer Res; 2017 Oct; 29(5):463-470. PubMed ID: 29142466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scrutinizing the Expression and Blockade of Inhibitory Molecules Expressed on T Cells from Acute Myeloid Leukemia Patients.
    Abdolmaleki M; Mojtabavi N; Zavvar M; Vaezi M; Noorbakhsh F; Nicknam MH
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):265-273. PubMed ID: 29908544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Lu Y; Liu S; Li Y; Chen S
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):143-149. PubMed ID: 33608984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and Significance of PD-1, TIM-3 and VISTA on T Cell of Acute Myeloid Leukemia Patients].
    Ge MJ; Xu KL; Xu T; Tang YN; Li ZY; Yan ZL; Sun HY; Cheng H; Zhu F; Sang W; Huang YH; Qiu TT; Li DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):748-752. PubMed ID: 32552931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
    Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
    Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia.
    Huang S; Zhao Y; Lai W; Tan J; Zheng X; Zha X; Li Y; Chen S
    Cancer Biol Ther; 2023 Dec; 24(1):2278229. PubMed ID: 37962843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A skewed distribution and increased PD-1+Vβ+CD4+/CD8+ T cells in patients with acute myeloid leukemia.
    Huang J; Tan J; Chen Y; Huang S; Xu L; Zhang Y; Lu Y; Yu Z; Chen S; Li Y
    J Leukoc Biol; 2019 Sep; 106(3):725-732. PubMed ID: 31136687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia.
    Chajuwan T; Kansuwan P; Kobbuaklee S; Chanswangphuwana C
    Leuk Lymphoma; 2022 Feb; 63(2):450-456. PubMed ID: 34585994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia.
    Zhou Q; Munger ME; Veenstra RG; Weigel BJ; Hirashima M; Munn DH; Murphy WJ; Azuma M; Anderson AC; Kuchroo VK; Blazar BR
    Blood; 2011 Apr; 117(17):4501-10. PubMed ID: 21385853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy.
    Dama P; Tang M; Fulton N; Kline J; Liu H
    J Immunother Cancer; 2019 Jul; 7(1):175. PubMed ID: 31291985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia.
    Huang Y; Zheng H; Zhu Y; Hong Y; Zha J; Lin Z; Li Z; Wang C; Fang Z; Yu X; Liu L; Xu B
    Front Immunol; 2023; 14():1139517. PubMed ID: 36960073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients.
    Wu K; Feng J; Xiu Y; Li Z; Lin Z; Zhao H; Zeng H; Xia W; Yu L; Xu B
    Int Immunopharmacol; 2020 Mar; 80():106122. PubMed ID: 31955066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C.
    Osuch S; Laskus T; Berak H; Perlejewski K; Metzner KJ; Paciorek M; Radkowski M; Caraballo Cortés K
    Sci Rep; 2020 Sep; 10(1):16060. PubMed ID: 32994477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment.
    Schnorfeil FM; Lichtenegger FS; Emmerig K; Schlueter M; Neitz JS; Draenert R; Hiddemann W; Subklewe M
    J Hematol Oncol; 2015 Jul; 8():93. PubMed ID: 26219463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.
    Noviello M; Manfredi F; Ruggiero E; Perini T; Oliveira G; Cortesi F; De Simone P; Toffalori C; Gambacorta V; Greco R; Peccatori J; Casucci M; Casorati G; Dellabona P; Onozawa M; Teshima T; Griffioen M; Halkes CJM; Falkenburg JHF; Stölzel F; Altmann H; Bornhäuser M; Waterhouse M; Zeiser R; Finke J; Cieri N; Bondanza A; Vago L; Ciceri F; Bonini C
    Nat Commun; 2019 Mar; 10(1):1065. PubMed ID: 30911002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.